TLE1 as a Diagnostic Immunohistochemical Marker for Synovial Sarcoma Emerging From Gene Expression Profiling Studies
- 1 February 2007
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Surgical Pathology
- Vol. 31 (2), 240-246
- https://doi.org/10.1097/01.pas.0000213330.71745.39
Abstract
Synovial sarcoma is a soft tissue malignancy defined by the SYT-SSX fusion oncogene. Demonstration of the t(X;18) by cytogenetics, fluorescence in situ hybridization or reverse-transcriptase polymerase chain reaction has become the gold standard for diagnosis, but practical considerations limit the availability of these methods. Gene expression profiling studies performed by several independent groups have consistently identified TLE1 as an excellent discriminator of synovial sarcoma from other sarcomas, including histologically similar tumors such as malignant peripheral nerve sheath tumor. TLE proteins (human homologues of Groucho) are transcriptional corepressors that inhibit Wnt signaling and other cell fate determination signals, and so have an established role in repressing differentiation. We examined the expression of TLE proteins in synovial sarcoma and in a broad range of mesenchymal tumors using tissue microarrays to assess the value of anti-TLE antibodies in the immunohistochemical confirmation of synovial sarcoma. We demonstrate that TLE expression is a consistent feature of synovial sarcoma using both a well-characterized monoclonal antibody recognizing the TLE family of proteins and a commercially available polyclonal antibody raised against TLE1. Both antibodies gave intense and/or diffuse nuclear staining in 91/94 molecularly confirmed synovial sarcomas. Moderate staining is occasionally seen in schwannoma and solitary fibrous tumor/hemangiopericytoma. In contrast, TLE staining is detected much less frequently and at lower levels, if at all, in 40 other mesenchymal tumors. Our findings establish TLE as a robust immunohistochemical marker for synovial sarcoma, and may have implications for understanding the biology of synovial sarcoma and for developing experimental therapies for this cancer.This publication has 30 references indexed in Scilit:
- Gene Expression Profiling of Human Sarcomas: Insights into Sarcoma BiologyCancer Research, 2005
- β-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activationNature Structural & Molecular Biology, 2005
- Should molecular testing be required for diagnosing synovial sarcoma?Cancer, 2003
- Molecular Genetics of Pediatric Soft Tissue Tumors: Clinical ApplicationThe Journal of Molecular Diagnostics, 2003
- Expression Profiling of Synovial Sarcoma by cDNA MicroarraysThe American Journal of Pathology, 2002
- All Tcf HMG box transcription factors interact with Groucho-related co-repressorsNucleic Acids Research, 2001
- Molecular mechanisms underlying human synovial sarcoma developmentGenes, Chromosomes and Cancer, 2000
- Groucho/TLE family proteins and transcriptional repressionGene, 2000
- Strong Association of SYT-SSX Fusion Type and Morphologic Epithelial Differentiation in Synovial SarcomaDiagnostic Molecular Pathology, 2000
- A functional interaction between the histone deacetylase Rpd3 and the corepressor Groucho in Drosophila developmentJournal of Bone and Joint Surgery, 1999